Close Menu

NEW YORK – Abbott Laboratories said Thursday that its first quarter Diagnostics business revenues declined slightly year over year.

For the three months ended March 31, Abbott reported overall Q1 revenues of $7.73 billion, up 3 percent from $7.53 billion in Q1 of 2019 and beating analysts' average estimate of $7.34 billion.

On an organic basis, revenues grew 4 percent year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.